Latest News about FDA
Recent news which mentions FDA
Pfizer, BioNTech File First For Emergency Use Authorization Of Coronavirus Vaccine
November 20, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
From Benzinga
Pfizer, Moderna COVID-19 Vaccines Could Get Limited EU Approval Before Year-End: Report
November 20, 2020
From Benzinga
From Benzinga
Pfizer Expected To File For FDA Emergency Approval on Friday, Followed Closely By Moderna, Azar Says
November 19, 2020
From Benzinga
From Benzinga
How Increased FDA Activity Can Benefit ETFs in Your Portfolio
November 19, 2020
From ETF Trends
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
November 19, 2020
From Benzinga
The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted
November 18, 2020
From Benzinga
FDA Gives Nod To First COVID-19 At-Home Rapid Test
November 18, 2020
From Benzinga
The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
November 17, 2020
From Benzinga
FDA Lifts Partial Clinical Hold On Inovio's Phase 2 Investigational Coronavirus Vaccine Study
November 16, 2020
Tickers
INO
From Benzinga
Moderna reports its COVID-19 vaccine is 94.5% effective in first data from Phase 3 trial
November 16, 2020
Tickers
TC
From TechCrunch
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.